HIGHLIGHTS
- who: SEC and collaborators from the Central South University, China have published the Article: Increased response to TPF chemotherapy promotes immune escape in hypopharyngeal squamous cell carcinoma, in the Journal: (JOURNAL)
- what: Enhanced glycolysis promoted immune escape, but increased response to TPF chemotherapy.
SUMMARY
Hypopharyngeal squamous cell carcinoma (HPSCC) is relatively rare and accounts for roughly 3% of all head and neck cancers (Garneau et_al, 2018; Zhang et_al, 2021). Patients with HPSCC frequently present at an advanced stage which is characterized by extensive local spread and early metastasis (Uzcudun et_al, 2001 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.